Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1978 4
1979 8
1980 8
1981 5
1982 14
1983 13
1984 16
1985 13
1986 10
1987 6
1988 1
1989 1
1990 1
1991 1
1992 2
1993 1
1995 5
1996 2
1998 1
1999 4
2000 2
2002 1
2003 4
2004 6
2005 12
2006 8
2007 4
2008 7
2009 15
2010 4
2011 5
2012 9
2013 14
2014 16
2015 17
2016 19
2017 8
2018 10
2019 18
2020 22
2021 28
2022 24
2023 9

Text availability

Article attribute

Article type

Publication date

Search Results

351 results

Results by year

Filters applied: . Clear all
Page 1
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, Edwards R, Agarwal R, Bakris G, Bull S, Cannon CP, Capuano G, Chu PL, de Zeeuw D, Greene T, Levin A, Pollock C, Wheeler DC, Yavin Y, Zhang H, Zinman B, Meininger G, Brenner BM, Mahaffey KW; CREDENCE Trial Investigators. Perkovic V, et al. N Engl J Med. 2019 Jun 13;380(24):2295-2306. doi: 10.1056/NEJMoa1811744. Epub 2019 Apr 14. N Engl J Med. 2019. PMID: 30990260 Free article. Clinical Trial.
The complex role of tumor-infiltrating macrophages.
Christofides A, Strauss L, Yeo A, Cao C, Charest A, Boussiotis VA. Christofides A, et al. Nat Immunol. 2022 Aug;23(8):1148-1156. doi: 10.1038/s41590-022-01267-2. Epub 2022 Jul 25. Nat Immunol. 2022. PMID: 35879449 Review.
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, Kuder JF, Wang H, Liu T, Wasserman SM, Sever PS, Pedersen TR; FOURIER Steering Committee and Investigators. Sabatine MS, et al. N Engl J Med. 2017 May 4;376(18):1713-1722. doi: 10.1056/NEJMoa1615664. Epub 2017 Mar 17. N Engl J Med. 2017. PMID: 28304224 Free article. Clinical Trial.
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; SONAR Committees and Investigators. Heerspink HJL, et al. Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140-6736(19)30772-X. Epub 2019 Apr 14. Lancet. 2019. PMID: 30995972 Clinical Trial.
Estimating the proportion of non-heterosexuals in Taiwan using Christofides' randomized response model: A comparison of different estimation methods.
Hsieh SH, Perri PF. Hsieh SH, et al. Soc Sci Res. 2021 Jan;93:102475. doi: 10.1016/j.ssresearch.2020.102475. Epub 2020 Sep 24. Soc Sci Res. 2021. PMID: 33308680
In this article, we consider the randomized response model proposed by Christofides (2003) and, through a simulation and an empirical study, compare different estimation methods for the prevalence of a sensitive attribute. ...
In this article, we consider the randomized response model proposed by Christofides (2003) and, through a simulation and an empirical …
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber LV, Lawson FC, Ping L, Wei X, Lewis EF, Maggioni AP, McMurray JJ, Probstfield JL, Riddle MC, Solomon SD, Tardif JC; ELIXA Investigators. Pfeffer MA, et al. N Engl J Med. 2015 Dec 3;373(23):2247-57. doi: 10.1056/NEJMoa1509225. N Engl J Med. 2015. PMID: 26630143 Free article. Clinical Trial.
351 results